Peer-reviewed veterinary case report
Gastrointestinal adenocarcinoma signs and outlook in Jack Russell
By Ohmi, Aki et al.·Published in The Journal of veterinary medical science·2021·Graduate School of Agricultural and Life Sciences, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Clinical and histopathological features and prognosis of gastrointestinal adenocarcinomas in Jack Russell Terriers.
- Species:
- dog
Plain-English summary
A group of Jack Russell Terriers (JRTs) diagnosed with gastrointestinal adenocarcinomas (a type of cancer) showed unique symptoms and outcomes compared to other breeds. The most common cancer sites were the pylorus (the opening from the stomach) and the rectum. While the survival time for JRTs with gastric adenocarcinoma was uncertain because many were still alive, non-JRT dogs had a median survival of just 34 days. For those with large intestine adenocarcinoma, JRTs had a much longer survival time compared to non-JRTs. This suggests that JRTs may need different treatment approaches than other breeds when dealing with this type of cancer.
People also search for: Jack Russell Terrier cancer prognosis · gastrointestinal adenocarcinoma treatment in dogs · dog stomach cancer survival rates
Abstract
There has been an increase in the number of Jack Russell Terriers (JRTs) diagnosed with adenomas and adenocarcinomas of the gastrointestinal tract in Japan. This study retrospectively investigated the clinical and histopathological features and prognosis of adenocarcinomas arising in the gastrointestinal tract in JRT dogs. Seven JRTs and 39 dogs of other breeds diagnosed with gastrointestinal adenocarcinoma were included in the study. The most common sites of gastrointestinal adenocarcinoma in JRTs were the pylorus and rectum. On histopathological examination, these adenocarcinomas showed a papillary or tubular growth pattern, and the lesions were confined within the mucosal epithelium and poorly invasive. Among all dogs with gastric adenocarcinoma, the median survival time (MST) for five of the JRTs could not be determined because more than half of the cases remained alive, while the MST for nine non-JRT dogs was 34 days. Among all dogs with adenocarcinoma in the large intestine, the MST for three of the JRTs could not be determined, while the MST for nine non-JRT dogs was 1,973 days. The difference in MST between JRT and non-JRT dogs with gastric adenocarcinoma was significant (P=0.0220). Since gastrointestinal adenocarcinomas in JRTs show distinct characteristics with respect to their clinical features, treatment course, and prognosis, a different surgical and medical treatment plan should be considered compared to the management of gastrointestinal adenocarcinomas in other dog breeds.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/33328390/